The QualityStocks Daily Tuesday, January 9th, 2024

Today's Top 3 Investment Newsletters

MarketClub Analysis(SNTG) $3.4700 +62.91%

FreeRealTime(ZCAR) $6.3900 +60.96%

QualityStocks(YCBD) $0.9349 +27.89%

The QualityStocks Daily Stock List

cbdMD Inc. (YCBD)

Schaeffer's, InvestorPlace, MarketBeat, QualityStocks, StockMarketWatch, The Street, FreeRealTime, CFN Media Group, Wealth Insider Alert, Top Pros' Top Picks, StreetInsider, Red Chip, Money Morning and MarketClub Analysis reported earlier on cbdMD Inc. (YCBD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

cbdMD Inc. (NYSE American: YCBD) is a pharmaceutical firm that is engaged in the production and distribution of cannabidiol (CBD) products.

The firm has its headquarters in Charlotte, North Carolina and was incorporated in 2015, on March 17th by Caryn Dunayer. Prior to its name change in May 2019, the firm was known as Level Brands Inc. It operates as part of the pharmaceutical and medicine manufacturing industry, in the health care sector. The firm has two companies in its corporate family and serves consumers in the United States.

The company operates and owns consumer hemp-based CBD brands like Paw CBD and cbdMD. It distributes its products through different brick and mortar retailers across the United States, as well as through wholesalers, 3rd party e-commerce sites and its e-commerce website.

The enterprise’s product categories include animal treats and oils, CBD-infused topical creams, CBD-infused bath bombs, CBD gummies, capsules and CBD tinctures. It provides veterinarian-formulated products like topicals, chews and tinctures under its Paw CBD brand. Under its cbdMD brand, it offers CBD sleep aids, CBD vape oils, CBD bath salts, bath bombs, CBD oil capsules, CBD topicals, CBD gummies and tinctures. All the enterprise’s products are THC-free and have undergone 3rd party testing to ensure their safety.

The company recently entered into an agreement with IM Cannabis Corp., which will facilitate the brand’s entrance into the Israeli market. In addition to bringing in more revenue, this move will help extend the company’s consumer reach and boost investments into the company.

cbdMD Inc. (YCBD), closed Tuesday's trading session at $0.9349, up 27.8933%, on 490,633 volume. The average volume for the last 3 months is 17,231 and the stock's 52-week low/high is $0.56/$17.055.

Yancoal Australia (YACAF)

We reported earlier on Yancoal Australia (YACAF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Yancoal Australia Limited (OTC: YACAF) (ASX: YAL) (HKG: 3668) (FRA: YA1) is a company focused on exploring for, developing, producing and marketing metallurgical and thermal coal in Australia, Bangladesh, Japan, Indonesia, Taiwan, Chile, South Korea, India, Europe, Thailand, Malaysia, and Vietnam.

The firm has its headquarters in Sydney, Australia and was incorporated in 2004, on November 18th. It operates as part of the thermal coal industry, under the energy sector. The firm serves consumers around the globe.

The enterprise operates as a subsidiary of Yankuang Energy Group Company Ltd. It holds 100% interests in the Ashton mine located in the Upper Hunter Valley region of New South Wales; the Stratford Duralie mine located within the New South Wales Gloucester Basin, the Stratford Duralie; and the Yarrabee mine located to the north east of Blackwater in Central Queensland's Bowen Basin. It also owns a 95% interest in the Moolarben coal mine located in the Western Coalfields of New South Wales; 80% interest in the Mount Thorley and Warkworth mines located in the Hunter Valley region of New South Wales; and 51% interest in the Hunter Valley Operations located to the north-west of Singleton in the Hunter Valley region of New South Wales. In addition to this, the enterprise owns a 50% interest in the Middlemount mine located to the north east of Emerald in Queensland's Bowen Basin; and various interests in sites located in Queensland, New South Wales, and Western Australia.

The company remains focused on its commitment to implementing a long-term strategy for growth and opportunity. This may positively influence investments into the company as well as help create shareholder value.

Yancoal Australia (YACAF), closed Tuesday's trading session at $3.7, up 1.3699%, on 2,000 volume. The average volume for the last 3 months is 278,531 and the stock's 52-week low/high is $2.92/$4.76.

Primech (PMEC)

We reported earlier on Primech (PMEC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Primech Holdings Ltd. (NASDAQ: PMEC) is a holding firm engaged in the provision of facilities and stewarding services in the public and private sectors in Singapore.

The firm has its headquarters in Singapore and was incorporated in 2020, on December 29th. It operates as part of the specialty business services industry, under the industrials sector. The firm serves consumers primarily in Singapore.

The enterprise operates as a subsidiary of Sapphire Universe Holdings Ltd. Its facilities services include general cleaning and maintenance of public and private facilities, such as conservancy areas, airports, refuse disposal areas, public areas, and parks and carparks of public housing units; educational institutions, common areas of hotels, public roads, residential spaces, office facilities, commercial buildings, industrial areas, retail stores, and healthcare facilities; housekeeping services; specialized cleaning services, including building façade cleaning, marble polishing, and clean room sanitation services; and waste management and pest control services. The enterprise also provides stewarding services comprising cleaning of the kitchen area of healthcare facilities, restaurants and hotels, as well as supplies ad hoc customer service officers, and food and beverage service crews to healthcare facilities, hotels, and restaurants. In addition to this, it manufactures and sells cleaning supplies, such as hand soap dispensers, hand soaps, cleaning fluids, and garbage bags used for floor, general, restroom, carpet, or kitchen purposes; and operates HomeHelpy, an online portal that allows individual customers to book cleaning services in homes and offices. It also manufactures and sells treatment products used in the marine industry under the D'Bond brand name.

The company, which recorded growth in its revenues over the last year, is focused on generating value for its shareholders.

Primech (PMEC), closed Tuesday's trading session at $2.01, even for the day, on 16,326 volume. The average volume for the last 3 months is 4,365 and the stock's 52-week low/high is $1.01/$4.18.

Destiny Media Technologies (DSNY)

QualityStocks, Wall Street Resources, StockEarnings, MarketBeat, StocksEarning, InvestorPlace, Stockhouse, SmallCapVoice, OTCPicks, Greenbackers,, Breaking Bulls and Blaque Capital Stocks reported earlier on Destiny Media Technologies (DSNY), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Destiny Media Technologies Inc. (OTCQB: DSNY) (CVE: DSY) (FRA: DME1) is a company focused on the development of technologies that enable the distribution of digital media files in a streaming or digital download format over the internet.

The firm has its headquarters in Vancouver, Canada and was incorporated in August 1998 by Gianpaolo Fabrisio Andreola. It operates as part of the software-application industry, under the technology sector. The firm serves consumers around the world.

The enterprise operates solely in the digital media software segment. Its offerings include Play MPE, an online platform that distributes promotional content, including broadcast quality audio, video, images, promotional information, and other digital content from record labels and artists to broadcasting professionals, music curators, and music reviewers to discover, download, broadcast, and review the content; Clipstream, an online video platform for encoding, hosting, and reporting on video playback that can be embedded in third party websites or emails; and Play MPE CASTER. It also offers Play MPE Quickshare provides a distribution tool for Play MPE customers to promote music; Play MPE Player for music curators to review and download content through cloud-based player and mobile apps; Music Tracking Radar, a digital tracking service that tracks and reports the number and times a customer’s track is played; and playback through its JavaScript codec engine. The enterprise markets and sells its products in Australia, the United States, Asia, Canada, Europe, South America, and Africa.

The company recently released its latest financial results, with its CEO noting that they had made significant progress on aspects in the Play MPE platform which should accelerate revenue growth and target market acquisition. This may positively influence investments into the company.

Destiny Media Technologies (DSNY), closed Tuesday's trading session at $0.9, off by 13.4615%, on 10,150 volume. The average volume for the last 3 months is 2,755 and the stock's 52-week low/high is $0.525/$1.19.

Phoenix Footwear (PXFG)

MarketBeat, QualityStocks, Zacks and reported earlier on Phoenix Footwear (PXFG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Phoenix Footwear Group, Inc. (OTC: PXFG) is a company focused on designing, developing, marketing and selling quality footwear for women.

The firm has its headquarters in Carlsbad, California and was incorporated in 1882. It operates as part of the footwear and accessories industry, under the consumer cyclical sector. The firm primarily serves consumers in the United States.

The enterprise specializes in comfort women’s footwear with a design focus on fitting features. Its footwear comes in a wide range of sizes and widths under the brands SoftWalk and Trotters. The Trotters brand is focused on providing customers with a wide range of sizes and widths in order to ensure the fitting shoes that customer can buy. The enterprise also distributes Los Cabos, Pendelton and Bueno Footwear Shoes. Its Bueno brand footwear combines colors with a balance of style and comfort. Bueno brand is sold in over 30 countries, including Australia, Japan, Germany, Canada, France, and Italy. Los Cabos is focused on researching, innovating and engineering new materials and constructions that offer progressive looks together with natural support and superior comfort in faux leather. Pendleton primarily focuses on rubber boots, among other footwear. The enterprise’s brands are primarily sold through department stores, specialty and independent retail stores, mail order catalogues and internet retailers in more than 900 retail locations throughout the U.S. Its wholly-owned subsidiaries include Penobscot Shoe Co.

The company remains committed to better meeting the needs of its consumers and creating avenues to generate additional value for its shareholders.

Phoenix Footwear (PXFG), closed Tuesday's trading session at $0.05665, even for the day. The average volume for the last 3 months is 8,684 and the stock's 52-week low/high is $0.05/$0.2183.

Planting Hope (MYLKF)

We reported earlier on Planting Hope (MYLKF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The Planting Hope Company Inc. (OTCQB: MYLKF) (CVE: MYLK) (FRA: J94) is a plant-based food and beverage firm focused on the production of nutritious and planet-friendly products.

The firm has its headquarters in Vancouver, Canada and was incorporated in 2020, on November 19th by Julia Stamberger, Matt Coffer, James Curley and Todd Bamberg. Prior to its name change in May 2021, the firm was known as Campio Capital Corp. It operates as part of the packaged foods industry, under the consumer defensive sector. The firm serves consumers across the globe.

The company operates through the Hope & Sesame, RightRice, Mozaics, and Veggicopia brands. The Hope & Sesame brand is focused on unlocking the nutritional potential of sesame, a sustainable seed cultivated worldwide in arid climates, and delivering that nutrition through delicious plant-based beverages and food. The RightRice brand is a delicious alternative to traditional rice and flavored rice blends that offer more than starch as nutrition. The Mozaics brand offers veggie chips with visible peas and beans in a popped snack chip, enabling the delivery of real nutrition from veggies in a low-calorie savory snack chip. The Veggicopia brand brings deliciousness to nutritious plant-based snacking, including single serving dip cups and snack olives.

The firm, which recently announced its latest financial results noting that it had realigned its strategy with capital markets expectations, remains committed to profitability, better meeting consumer needs and meeting the growing demand for its products. This may in turn bring in additional revenues into the firm while bolstering its overall growth.

Planting Hope (MYLKF), closed Tuesday's trading session at $0.16, even for the day. The average volume for the last 3 months is 298,236 and the stock's 52-week low/high is $0.002/$1.00.

TerrAscend Corp. (TSNDF)

QualityStocks, InvestorPlace and Cabot Wealth reported earlier on TerrAscend Corp. (TSNDF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Wisconsin may be the latest state to pass cannabis reform measures after a bipartisan group of lawmakers formally introduced a proposal to decriminalize cannabis possession in late December. First previewed in early December, the noncommercial and relatively limited reform may garner enough support to advance past Wisconsin’s GOP-controlled legislature.

The marijuana decriminalization measure was introduced by Representatives David Considine, Sylvia Ortiz-Velez and Shae Sortwell alongside Senator Lena Taylor. Assembly Bill 861 would remove criminal penalties such as jail time for cannabis-related offenses, such as simple possession of up to 14 grams of marijuana, and replace criminal charges for cannabis offenses with a $100 civil penalty.

Current Wisconsin law criminalizes cannabis possession and punishes the offense with a maximum of six months in jail and a $1,000 fine.

The proposed decriminalization measure would also eliminate the need for people charged with cannabis possession to appear in court and replace it with a simple $100 fine. Additionally, the decriminalization measure would stop Wisconsin courts from counting cannabis possession convictions that involve up to 28 grams of cannabis. This means Wisconsin residents would never again be charged as repeat offenders for possessing small amounts of marijuana.

The measure also reduced penalties for repeatedly possessing larger amounts of cannabis from three and a half years imprisonment to 90 days. Individuals charged with drug paraphernalia possession will be liable to a $10 civil forfeiture fine down from as much as 30 days in jail and a $500 fine.

According to a censorship memo released by the measure’s sponsors, Wisconsin should not be imprisoning its residents for simply possessing small amounts of cannabis. On average, Wisconsin makes 15,485 arrests for minor cannabis possession and punishes simple possession suspects with up to six months in jail and a maximum $1,000 fine. The proposed measure would also grant law enforcement more flexibility on how they choose to deal with individual cannabis possession cases. This includes deciding whether or not to book and process individuals for simple cannabis possession or simply collecting certain personal information.

The measure would also reduce the liability of employers who choose not to test their employees for THC. However, these workplace testing provisions would not apply to jobs involving security and safety or those overseen by the federal Department of Transportation. The sponsorship memo noted that employers are increasingly choosing to forgo cannabis tests because they can be costly.

Assembly Bill 861 will head to the Assembly Committee on Criminal Justice and Public Safety.

If this reform movement results in the eventual legalization of cannabis, it could lead existing companies such as TerrAscend Corp. (TSX: TSND) (OTCQX: TSNDF) to weigh whether or not to expand their footprints into those new markets.

TerrAscend Corp. (TSNDF), closed Tuesday's trading session at $1.8, off by 2.7027%, on 287,782 volume. The average volume for the last 3 months is 423,162 and the stock's 52-week low/high is $1.15/$2.3407.

Compass Minerals International Inc. (CMP)

SmarTrend Newsletters, QualityStocks, MarketBeat, The Online Investor, DividendStocks, Daily Trade Alert, Trades Of The Day,, The Street, InvestorPlace, Kiplinger Today, MiningNewsWire, Zacks, StreetAuthority Daily, Schaeffer's, StreetInsider, All about trends, MarketClub Analysis, The Stock Dork, Insider Wealth Alert, Top Pros' Top Picks, Daily Wealth, Wyatt Investment Research, Daily Market Beat, CRWEFinance, BUYINS.NET and Barchart reported earlier on Compass Minerals International Inc. (CMP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A Kings Research study has predicted that the global organic-fertilizer sector will grow at a compound annual growth rate (CAGR) of 1.31% to generate revenue worth $27.48 billion by 2030. Organic fertilizers are developed using organic sources such as cattle manure, organic compost, domestic sewage and poultry droppings.

Although organic fertilizers typically have a lower nitrogen, potassium and phosphorous profile compared to synthetic fertilizers, they can provide plants with nutrients for a much longer period. Additionally, organic fertilizers are cheap and can stimulate healthy root development; improve soil texture, aeration, and structure; and increase water-retention abilities.

Unlike chemical or synthetic fertilizers, which regularly cause pollution and can reduce soil fertility by changing its nature and harming soil microbes, organic fertilizers enrich the soil and ensure it is fertile and productive over the long-term.

The global market for organic fertilizers was around $9.6 billion in 2022, and Kings Research expects it to grow rapidly over the next six years. With the world going through a fertilizer crisis that threatened food supplies in several countries, organic fertilizers have been gaining popularity due to their low costs and significantly high return on investment.

While the global agriculture sector has relied on chemical fertilizers quite heavily to increase crop and soil production, organic fertilizer use is on the rise as people become increasingly aware of the public-health and environmental drawbacks of relying entirely on synthetic fertilizers for food production. Experts predict that people’s increasing readiness to pay extra for organic foods could boost the uptake of these fertilizers through the decade.

Increasing demand for organic foods from major markets such as North America and Europe will be instrumental in bolstering the adoption of organic fertilizers, particularly in the Asia-Pacific where these two markets import their food. The European Union has already earmarked 30% of its annual budget for the Common Agricultural Policy (CAP) program for rural growth to support and promote organic farming.

Rural populations may be especially receptive to organic farming practices because they don’t require the advanced agricultural methods used with chemical fertilizers while also being significantly cheaper. Organic fertilizers have the potential to essentially revolutionize the global agriculture industry if they are applied correctly. They could significantly limit soil damage during growing seasons and preserve the soil’s life-giving abilities, allowing farmers to grow healthier organic food for much longer without compromising the soil’s fertility.

For those who aren’t yet convinced about the economy of using organic fertilizers, commercial synthetic plant nutrients from enterprises such as Compass Minerals International Inc. (NYSE: CMP) that are readily available around the world may suffice.

Compass Minerals International Inc. (CMP), closed Tuesday's trading session at $20.55, off by 5.9066%, on 806,959 volume. The average volume for the last 3 months is 148,098 and the stock's 52-week low/high is $20.50/$47.68.

Cenntro Electric Group Ltd. (CENN)

QualityStocks, GreenCarStocks, TradersPro, Penny Stock and InvestorPlace reported earlier on Cenntro Electric Group Ltd. (CENN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A new Chinese electric vehicle brand with Volkswagen’s backing has debuted the industry’s first sodium-ion battery-powered electric car. JAC Group’s Yiwei rolled out the new JAC Yiwei EV in late December. Yiwei was established in early 2023 under the JAC Group, and its parent company is jointly owned by the Chinese government and Volkswagen.

The German automaker bought a 50% stake in the JAC group for $1.09 billion and also assumed full control of its existing EV joint venture’s management with a 75% stake. Yiwei leveraged its backing from Volkswagen and the Chinese government to manufacture the first EV in the nascent electric vehicle industry to use cylindrical sodium-ion cells from Beijing-based tech firm HiNa Battery rather than the standard lithium-ion batteries.

Yiwei’s new EV will use UE modular tech from JAC that features a honeycomb structure. This is similar to the Blade battery, which was developed by BYD and is used to power Ford, Kia and Toyota EVs. JAC’s UE modular battery technology also shares similarities with cell-to-pack technology (CTP) from battery manufacturing giant Contemporary Amperex Technology Co. (CATL).

JAC first unveiled the Yiwei 3 in February 2023 at the Shangai Auto Show with an LFP battery but promised that upcoming versions would feature the sodium-ion battery. The Chinese automaker also introduced the Sehol E10X, a sodium-ion battery-powered hatchback EV with 120 Wh/kg of energy density, 25 kWh of capacity and the ability to charge from 10% to 80% in 20 minutes.

Volkswagen moved the Sehol brand to JAC in 2021, and JAC noted in 2023 that EVs in the brand would either wear the Yiwei or JAC badge. While the sodium-ion batteries powering Yiwei’s electric cars have less energy density compared to lithium-ion alternatives, they offer numerous other advantages. Sodium-ion batteries generally have longer lifespans, increased durability, faster charging speeds, better performance in low temperatures and are significantly more resistant to battery fires.

Furthermore, they require cheaper raw materials and are less costly to produce, directly translating into more affordable electric cars for the consumer. Yiwei Tech chairman Xia Shunli notes that sodium-ion batteries will be an important battery chemistry that could act as a low-cost solution and accelerate mass electric vehicle adoption.

The low-energy density of the batteries makes them relatively unsuitable for larger electric pickups and trucks, but they could be effective in lower-end, short-range EVs or for stationary power grid storage. Sodium-ion batteries could result in significant cost-savings for car manufacturers, and automakers such as Cenntro Electric Group Ltd. (NASDAQ: CENN) could take up this technology on a large scale once it proves itself in the field.

Cenntro Electric Group Ltd. (CENN), closed Tuesday's trading session at $1.42, off by 2.069%, on 120,454 volume. The average volume for the last 3 months is 551,652 and the stock's 52-week low/high is $1.21/$8.71.

Mind Medicine Inc. (MNMD)

QualityStocks, InvestorPlace, Schaeffer's, MarketBeat, The Wealth Report, The Street, The Stock Dork, MarketClub Analysis, Daily Trade Alert and Trades Of The Day reported earlier on Mind Medicine Inc. (MNMD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A small clinical trial involving military veterans suggests that a psychedelic called ibogaine has the potential to treat traumatic brain injury (TBI) symptoms such as depression and post-traumatic stress disorder (PTSD). The Stanford University study found that the lesser-known psychedelic reduced depression and PTSD symptoms by more than 80% in veterans with TBIs.

While the past few years have seen a surge of psychedelic-related studies and clinical trials, most of them have focused on classic psychedelics such as psilocybin (magic mushrooms), MDMA and LSD. These studies found that these popular psychedelics can be effective at treating the symptoms of various mental ailments, especially when they are combined with traditional talk therapy.

The recent study now adds ibogaine to the list of psychedelics that have the potential to treat debilitating mental disorders, including post-traumatic stress disorder and depression. Study coauthor and Stanford University neuroscientist Nolan Williams says that ibogaine seems to deliver a “broad, dramatic and consistent effect.”

The psychedelic is made from the bark of a central African shrub called Tabernanthe iboga and was traditionally used for ceremonial purposes.

According to Maria Steenkamp from the NYU Grossman School of Medicine, scientists have avoided researching the psychedelic for uses other than opioid dependence and withdrawal because it can cause fatal heartbeat irregularities and is strictly regulated in many nations. However, with more people failing to respond to conventional mental-health treatments such as therapy and antidepressants, Steenkamp says we “desperately need” new medical interventions.

Williams and his research team followed 30 U.S. veterans who went to a facility in Mexico where they purchased and took ibogaine alongside a magnesium supplement to reduce cardiac side effect risks. The research team reported an average 88% reduction in PTSD symptoms, an 87% drop in depression symptoms and an 81% reduction in anxiety symptoms one month after the ibogaine treatment. Furthermore, participants who had mild-to-moderate disabilities before treatment exhibited no disability one month after treatment, and none of the study participants had cardiac side effects.

Another study by researchers from the University of California posits that ibogaine may deliver its benefits by temporarily “reopening a critical period” where the nervous system is especially malleable.  Steenkamp says that the study, which had no control group, was a “proof of concept” that proper ibogaine screening and administration could reduce the risks of deadly side effects.

The research team plans to use biomarkers and neuroimaging to learn how ibogaine works and figure out if it can provide long-term mental-health benefits.

Meanwhile, other research teams at companies such as Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) are also making headway in developing therapeutic formulations from other psychedelics, including psilocybin. The mental-health field as we know it looks set for a major transformation in the coming years.

Mind Medicine Inc. (MNMD), closed Tuesday's trading session at $4.33, off by 1.3667%, on 669,340 volume. The average volume for the last 3 months is 2.948M and the stock's 52-week low/high is $2.41/$5.01.


InvestorPlace, Schaeffer's, StockEarnings, StocksEarning, QualityStocks, MarketBeat, Trades Of The Day, Daily Trade Alert, BUYINS.NET, The Street, Kiplinger Today, The Online Investor, StreetInsider, Early Bird, CNBC Breaking News, FreeRealTime, Investopedia, MarketClub Analysis, StockMarketWatch and MarketClub reported earlier on SNDL Inc. (SNDL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Clarence Cocroft, the owner of Tru Source, a medical marijuana dispensary in Olive Branch, Mississippi, is contending that the ban on medical marijuana advertising in Mississippi is hindering his dispensary’s ability to attract customers. He claims that this prohibition infringes upon his freedom of speech, a claim central to the federal suit filed on Nov. 14, 2023.

The lawsuit targets the regulatory authorities overseeing these restrictions, including the state’s health department, the revenue department, and the state’s bureau of alcohol and beverage control.

While medical cannabis is now legal in Mississippi for persons with qualifying conditions and a medical marijuana card, the state law explicitly forbids dispensary owners and cultivators from promoting marijuana products. To establish a medical marijuana shop, one is required to obtain a dispensary license, obtain a sales tax registration and incur considerable fees. Additionally, patrons must possess a medical marijuana card and be at least 21 years old to enter a dispensary.

Tru Source relies on limited advertising channels, including word of mouth, on-location signage and its website. Cocroft, however, faces restrictions preventing him from promoting the dispensary through other mediums. He highlights that potential customers might remain unaware of the store’s existence unless they happen to pass by.

Represented by the Institute for Justice (IJ), a nationwide libertarian nonprofit law firm, Cocroft’s lawsuit challenges the constitutionality of commercial speech regulations. Katrin Marquez, an attorney for Cocroft, points out how these regulations, viewed through the lens of the First Amendment, impede business growth.

When Tru Source was established, Cocroft invested in billboards in the north of the state for advertising but had to lease the locations to other businesses, such as a casino, capable of legally promoting their products. The case and the resultant media attention have attracted new customers to Tru Source, increasing daily visits from about 15 to 20 patients to 20 to 30 patients picking up medical marijuana products.

Cocroft argues that the ban on advertising not only affects dispensary owners but also impacts cultivators. If dispensaries can’t promote products, their purchasing capacity diminishes, causing financial losses for cultivators. He questions the disparity, noting that industries such as alcohol, medications, casinos and strip clubs can advertise statewide, while marijuana dispensaries face restrictions.

Cocroft highlights the financial burden borne by those invested in Mississippi’s medical marijuana industry, where millions of dollars have been spent in pursuit of helping patients navigate a novel business landscape. In his view, the unequal advertising regulations create a puzzling dichotomy where certain industries can freely advertise, while others, such as Tru Source, face stringent limitations.

It isn’t just cannabis companies in Mississippi that are hamstrung by restrictions on advertising. Other enterprises operating elsewhere, such as SNDL Inc. (NASDAQ: SNDL), are also grappling with limitations on how and where they can advertise their products.

SNDL Inc. (SNDL), closed Tuesday's trading session at $1.57, off by 5.988%, on 5,457,605 volume. The average volume for the last 3 months is 304,170 and the stock's 52-week low/high is $1.25/$2.48. (NEXCF)

QualityStocks, SeriousTraders, SmallCapRelations, Stocks to Buy Now, NetworkNewsWire, InvestorBrandNetwork, MissionIR,, TradersPro, MarketClub Analysis, StocksToBuyNow, CFN Media Group, Kiplinger Today, InvestorPlace, StockEarnings, Trades Of The Day and MarketBeat reported earlier on (NEXCF), and today we highlight the Company, here at the QualityStocks Daily Newsletter. (OTCQX: NEXCF) (CSE: NTAR) (FSE: 1SS), an AI-3D model supplier for major e-commerce retailers, started off the new year with six contracts. Five of the contracts were renewals with existing customers, including CB2, a division of Crate and Barrel; Artika, renowned for its avant-garde lighting solutions; Raptor Tactical, a designer and manufacturer of modern tactical equipment for military, police and other law enforcement units; William Wood Mirrors; and City Grounds, which offers a curated selection of high-quality merchandise tailored to the urban cycling lifestyle. The company also added a new customer to its portfolio: EOD Gear, which supplies EOD and tactical gear to EOD techs and commands, SWAT and individuals. According to the announcement, the company anticipates growing sales opportunities in its 3D modeling pipeline and notes that these contracts reflect a diverse range of industries, which illustrates the broad applicability and demand for's services. “As we start the new year, I am very optimistic about the trajectory of,” said CEO Evan Gappelberg in the press release. “When we look at the diverse range of contracts, renewals and the enthusiastic interest we're receiving, it reaffirms our conviction as AI/AR and 3D industry leaders. I’m especially pleased with our AI engineers who’ve created value for our business, which is evident by the recent launch of our AI-powered 3D model search engine tool. We are actively building and launching new breakthrough AI for the mass scale of 3D models and continuing to apply for and develop new patents around our proprietary AI technology.”

To view the full press release, visit

About is a versatile augmented reality, artificial intelligence (“AI”) technology company that utilizes its proprietary AI to craft immersive 3D experiences at scale for e-commerce. The company's primary focus lies in creating high-quality 3D WebAR photorealistic models for various e-commerce retailers. has adopted a unique approach to creating shareholder value beyond its operating business of creating 3D models. The company also develops or acquires disruptive AI technologies, which are subsequently spun out to shareholders as standalone public companies. This spin-out strategy allows to issue stock dividends to its shareholders while maintaining significant ownership in the public spin-out, without dilution to the parent company Notably, successfully spun out ARway (OTCQB: ARWYF) (CSE: ARWY) (FSE:E65), its spatial computing platform, as a standalone public company in 2022. The company retains a 49% stake with 13 million shares in ARway Corp. while distributing four million shares to Nextech shareholders. Similarly, accomplished its second spinout, launching (OTCQB: TGGLF) (CSE: TGGL) (FSE: Q0C), an AI-powered, 3D-design studio aimed at competing with Adobe. The company retains a 44% stake with 13 million shares in Corp. For more information about the company, please visit (NEXCF), closed Tuesday's trading session at $0.1769, up 6.6305%, on 122,665 volume. The average volume for the last 3 months is 35,126 and the stock's 52-week low/high is $0.078/$0.835.

The QualityStocks Company Corner

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF)

The QualityStocks Daily Newsletter would like to spotlight Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF).

Canadian metals supply company Ucore Rare Metals Inc. recently announced completion of the third and final stage of its Demonstration Plant commissioning process for the separation of critical rare earth element ("REE") metals used in various important technologies

The commissioning process is a key part of the company's demonstration of its proprietary RapidSX(TM) REE processing technology as it prepares for commercial production

Ucore is at the forefront of companies attempting to break China's virtual monopoly on REE production and separation processes by developing American-based supply chain solutions

The company will now focus on proving its RapidSX(TM) technology in response to U.S. and Canadian government-funded projects seeking a direct techno-economic comparison between conventional solvent extraction ("CSX") and RapidSX(TM)

Ucore will also begin work on building its commercial operation for REE separation using RapidSX(TM) in Louisiana this month

Strategic metals supply chain innovator Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF) recently completed the commissioning of its superior technology being put to the test for commercial use in separating heavy and light rare earth elements (HREEs, LREEs, or REEs) that are key ingredients in permanent magnets helping to drive modern computerized products. Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a leading developer of rare earth element ("REE") processing technology, announced the execution of a nonbinding Memorandum of Understanding ("MOU") with Defense Metals Corp. According to the announcement, the MOU defines an enhanced working relationship between the two companies as they collaborate to  explore opportunities as they move toward commercialization efforts for a North American rare earth element ("REE") supply chain. One of the first projects entails Defense Metals shipping a mixed rare earth carbonate sample from its Wicheeda REE deposit to Ucore's RapidSX(TM) Commercialization and Demonstration Facility in Ontario. According to the announcement, the sample will be shipped for testing in the next few weeks. This sample was generated last year during hydrometallurgical piloting test work performed on concentrate produced by earlier flotation pilot plant testing of a 26-tonne bulk sample from Defense Metal's British-Columbia-based Wicheeda Property. "The opportunity to align closer with Defense Metals is strategically important," said Ucore Rare Metals chair and CEO Pat Ryan in the press release. "The MOU lays out the framework wherein Defense Metals' technically strong and readily accessible North American REE resource can be further processed and refined using Ucore's Canadian-founded technology, RapidSX. Receiving the sample mixed rare earth carbonate at our Kingston CDF will start the process of determining what may be possible between the companies as we collectively look to fuel the 21st-century energy transition."

To view the full press release, visit

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) is a critical metals (“CM”) separation technology company executing an ESG-centered plan toward establishing a comprehensive North American critical metals supply chain. The company has developed a transformative commercial-ready technology, RapidSX™, for separating and purifying critical metals. Ucore intends to deploy this technology in pursuit of a CM supply chain independent of China for Western original equipment manufacturers (“OEMs”), most notably in the automotive and renewable energy industries.

Ucore’s vision is to become a leading advanced technology company providing best-in-class metal separation products and services to the mining and mineral extraction industry. Its initial focus is on processing heavy and light rare earth elements (“REEs”), disrupting a supply chain that is dominated by China.

China currently controls about 80% of the world’s access to REE mining projects and over 90% of the world’s REE processing capabilities, and it produces about 95% of the goods containing REE components.


Ucore is working to scale Western supply needs by establishing REE separation and rare earth oxide (“REO”) production capabilities in cooperation with strategic upstream supply and downstream offtake partnerships. The company, along with its industry partners, aims to unlock access to Western REEs for current consumer, energy, manufacturing and military sectors.

By 2025, Ucore expects to commercially separate U.S.-friendly sources of REEs and supply OEMs with REOs required to produce rare earth permanent magnets (“REPMs”) – the essential component of electric motors and generators required to support the world’s transition to electrification and sustainable energy sources.

The company intends to contribute to this initiative through the near-term development of a heavy and light rare-earth processing facility in Louisiana and subsequent development of Strategic Metals Complexes (SMCs) in Alaska and Canada, as well as through the longer-term development of its 100%-owned Heavy Rare Earth Element (HREE) mineral resource property at Bokan Mountain on Prince of Wales Island, Alaska.

Ucore is headquartered in Halifax, Nova Scotia.

Projects & Technology

RapidSX™ Demonstration Plant

The Kingston, Ontario, RapidSX™ Demonstration Plant commissioning process is underway. Once commissioned, the plant is designed to demonstrate the commercial capabilities of the RapidSX technology platform.

The RapidSX demo plant will show:

  • The techno-economic advantages of the RapidSX technology platform
  • The processing of tens of tons of heavy and light mixed rare earth element concentrates in a simulated production environment
  • The platform’s ability to operate for thousands of semi-continuous run-time hours
  • Production of high-purity NdPr, praseodymium, neodymium, terbium and dysprosium rare earth elements for early OEM product qualification trials

The demo plant is located within Ucore’s 5,000-square-foot RapidSX Commercialization and Demonstration Facility and is run by its laboratory partner, Kingston Process Metallurgy Inc. (“KPM”).

RapidSX™ Technology

Innovation Metals Corp., acquired by the company in 2020, developed the RapidSX separation technology platform with early-stage assistance from the United States Department of Defense, later resulting in the production of commercial-grade, separated rare earth elements at pilot scale.

RapidSX combines the time-proven chemistry of conventional solvent extraction (SX) with a new column-based platform that significantly reduces time to completion and plant footprint, as well as potentially lowering capital and operating costs. SX is the international REE industry’s standard commercial separation technology and is currently used by all REE producers worldwide for bulk commercial separation of both heavy and light REEs.

Utilizing similar chemistry to conventional SX, RapidSX is not a “new” technology, but it represents a significant improvement on the well-established, well-understood, proven conventional SX separation technology preferred by REE producers.

Strategic Metals Complex

Ucore, engineering partner Mech-Chem Associates Inc. and KPM are developing the full-scale engineering for the company’s first Strategic Metals Complex (SMC). The SMC is a planned REE separation and rare earth oxide production plant slated to commence construction in Louisiana in 2023. It is scheduled to initially process 2,000 tons of total rare earth oxides by the end of 2024, increasing to 5,000 tons in 2026.

The company has three initial U.S.-friendly feedstock agreements in place for the Louisiana complex, along with multiple developing offtake agreements. It received a C$16 million+ incentive package offer from Louisiana Economic Development to support construction of the SMC.

Bokan-Dotson Ridge REE Deposit

Ucore has invested over C$35 million to establish and validate the Bokan-Dotson Ridge resource in preparation for mine design and permitting. Initial drilling is complete, and a Preliminary Economic Assessment has been issued. Next steps for the project include a feasibility study, detailed mine design and permit acquisition. The project can be “near shovel ready” for construction in less than 30 months after receipt of the next stage of development funding.

Market Opportunity

According to a report by Grand View Research, the global rare earth elements market was valued at $2.8 billion in 2018 and is forecast to reach a value of $5.6 billion by 2025, achieving a CAGR of 10.4% during the period. Market growth is driven by increasing demand for these elements in the manufacturing of magnets and catalysts for the automotive industry. Rising demand for electric vehicles to reduce CO2 emissions is expected to propel the use of permanent magnets in the production of EV batteries.

China is the major producer and consumer of REEs. To maintain self-sufficiency and to meet future demand, China has been raising the export tariffs on rare earth elements shipped to various countries, including the U.S., Japan, India, Brazil and the European Union. This led to the current supply-demand gap in these countries, as they rely on imports from China.

China reduced the exports of REEs by 72% in the second half of 2010 to preserve its reserves of these elements and continues to export REEs at reduced levels, thereby affecting industries such as automotive, oil and gas, and electronics, which require an ample amount of rare earth elements.

Management Team

Pat Ryan, P.Eng., is Chairman and CEO of Ucore Rare Metals. He began as a director with the company when he developed a heightened interest in critical metals. Before joining Ucore, he founded and led a multimillion-dollar automotive OEM design and lean manufacturing company. His understanding of complex supply chains across international markets has led to a prime positioning as the global auto industry transitions to vehicle electrification. He holds a Bachelor of Engineering degree from Dalhousie University.

Peter Manuel is Vice President and CFO of Ucore. Prior to joining the company, he practiced as a Chartered Accountant for more than 17 years, providing consulting services to companies in a range of industries, with a focus on the financial services and resource sectors. He spent 10 years in England and Ireland providing assurance, strategic planning, corporate finance and other consulting services to a portfolio of both public and private entities. He holds a Bachelor of Commerce Degree from Dalhousie University.

Michael Schrider, MEng, P.E., is Vice President and COO of Ucore. He is a multidisciplinary engineer who has been involved in manufacturing, engineering and managing complex structural and mechanical systems projects since 1989. He was the Founder, President and Chief Engineer of Schrider & Associates and Alton Bay Design, both engineering services firms. He holds a bachelor’s degree in naval architecture and marine engineering from the University of New Orleans and a master’s degree in mining, geological and geophysical engineering from the University of Arizona.

Mark MacDonald is Vice President of Investor Relations at Ucore. He has over 25 years of experience implementing award winning business development and marketing programs at regional and national levels. As Vice President of Sales, he was responsible for Mediapro Communication’s growth as AT&T Canada’s leading B2B sales partner. He subsequently became Atlantic Regional Vice President of AT&T Canada Corp. He holds a Bachelor of Commerce degree from Dalhousie University.

Ucore Rare Metals Inc. (UURAF), closed Tuesday's trading session at $0.698, up 3.2544%, on 77,043 volume. The average volume for the last 3 months is 3.714M and the stock's 52-week low/high is $0.395/$1.15.

Recent News


The QualityStocks Daily Newsletter would like to spotlight SOHM Inc. (OTC: SHMN).

A newly found compound, CBD3063, has shown that it can be significantly effective at treating chronic pain in animal studies with barely any side effects. Scientists discovered the compound after screening a whopping 27 million potential drugs extensively. CBD3063 works by targeting the Cav2.2 calcium channel in a way researchers have never seen before and has shown that it can surpass existing pain-relief medications such as gabapentin in terms of efficacy. The research team published its findings in the "Proceedings of the National Academy of Sciences" (PNAS) journal. Scientists are currently working to refine the compound before introducing it to clinical trials as a more effective and side-effect-free chronic pain medication. Further research on novel pain medications is being undertaken by startups that also commercialize generic pain medications, such as SOHM Inc. (OTC: SHMN). SOHM (OTC: SHMN), a pharmaceutical, nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, has filed a provisional patent application on its ABBIE Smart Gene-Editing platform. According to the announcement, the platform uses the latest enzymes and guide RNAs to resolve off-target gene-editing limitations. Gene therapy modifies or manipulates the expression of a gene or alters the biological properties of living cells for therapeutic use and has become a critical tool for treating genetic diseases. One of the challenges of gene therapy, however, is ensuring that gene edits happen at the intended site and not off target. Off-target editing can cause tissue damage and transform healthy cells into cancerous cells. SOHM's ABBIE platform resolves off-target edits and improves precision. It's cell-engineering tools and systems can reduce off-target edits by not inducing double-stranded breaks and providing the power of retroviral integration without using a virus. The provisional patent filing covers detailing technology designed to control editing events more tightly and to leverage effector molecules, such as kinases and phosphatases, to regulate the activity of engineered DNA at a target site. SOHM also noted that the platform will utilize advances in graphene-based nanomaterials, nano sensors and wireless communication technologies allowing for enhanced control and fine-tuning of the gene editing process. The company is working closely with leading researchers and institutions to use graphene nanoparticles to advance the field of genome editing. "We are thrilled to introduce this game-changing technology to the world," said SOHM COO Dr. David Aguilar, PhD, in the press release. "Graphene nanoparticles have the potential to revolutionize genome editing, offering unprecedented precision and efficiency. We believe this breakthrough will have a profound impact on human health and open up new possibilities for scientific research as more gene therapies continue to pass FDA approvals."

To view the full press release, visit

SOHM Inc. (OTC: SHMN) is a generic pharmaceutical manufacturing and marketing company with a vision of “Globalè Prospèro” (Global Prosperity). SOHM was founded in 1998 and is headquartered in Chino Hills, California.

The company’s primary goal is to create and produce cutting-edge generic medications that span a wide range of treatment areas, all while ensuring top-tier quality and keeping prices affordable. SOHM is dedicated to fully complying with all relevant regulatory prerequisites and upholding the most rigorous industry benchmarks, including the guidelines set forth by WHO-CGMP and USFDA.

Achievements and Milestones

SOHM is a recognized generic pharmaceutical manufacturer, with production and marketing of generic drugs covering all major treatment categories. SOHM also markets innovative formulations and packaging for various therapeutic segments, such as cosmeceuticals, nutraceuticals and OTC oral dosage formulations, with operations spanning India, the Philippines, Uganda, the U.S., the UK and the EU.

SOHM successfully launched a unique and innovative Salic-2 face wash, FōHM by SOHM, during the Oscar after party in Hollywood. The innovative Salic-2 offering in translucent gel form is marketed as an acne medication in the U.S. cosmeceutical market.

With proficiency in both manufacturing and marketing, SOHM stands out. The company holds licenses for producing over 300 products and has established distribution partnerships with firms in the United States, the Philippines and Uganda. Additionally, SOHM’s repertoire includes the launch of an innovative protein supplement, I-Prolec, featuring a distinct composition—a first-of-its-kind in India.

In 2012, SOHM gained recognition as “the most emerging company in the recent past” at the National Integrated Medical Association Conference. The company’s growth was underscored by its inclusion in the roster of ‘Fastest Growing Public Companies’ according to the Orange County Business Journal.

SOHM Today

SOHM brings all of its expertise and market knowledge toward a new vision. The company continues to develop, manufacture and market generic pharmaceutical drugs for various treatment categories. It offers its products in various dosage forms, including tablets and capsules, creams and topicals, ointments and liquids. The company also provides anti-arthritic/analgesics, dermatological drugs, gastrointestinal and respiratory drugs, biotechnology products, anesthetics, immunosuppressive agents and other various treatments. In addition, it offers a skincare line that includes dry dermatoses, mixed skin infection, acne vulgaris and seborrheic dermatitis products.

SOHM markets its products directly and through partner alliance agreements to drug wholesalers, mass merchandisers, chain drug stores and mail-order pharmacies primarily in the U.S. and has previously done business in the Far East, Africa and Southeast Asia. The company is working with its alliance partner in the African continent and Latin American countries.

SOHM has developed a comprehensive marketing strategy encompassing a diverse range of tactics to promote all products. SOHM uses the power of digital marketing channels, social media campaigns and targeted advertising to significantly enhance awareness and recognition of product offerings.

All distribution networks are strengthened through valuable partnerships. SOHM has gained access to the extensive U.S. market through a strategic alliance with different wholesalers catering to C-stores and retailers. The company has likewise partnered with a distribution firm that holds a remarkable network of more than 4,500 independent pharmacy accounts.

Additionally, a strong partnership with a prominent distribution network in New Jersey enables SOHM to facilitate nationwide distribution to big distribution houses, hospitals and retail chain stores which include but are not limited to Walmart, Publix, Sam’s and many more retail giants, thus extending the company’s market presence.

SOHM Long-Term

A report by Grand View Research estimated the global nutraceuticals market at $291.33 billion in 2022 and forecasts expansion at a compound annual growth rate (CAGR) of 9.4% from 2023 to 2030. The report states primary factors driving the market growth are preventive health care, increasing instances of lifestyle-related disorders, and rising consumer focus on health-promoting diets. Additionally, increasing consumer spending power in high-growth economies is projected to contribute to the growing demand for nutraceutical products.

Grand View valued the global NSAID market at $19.55 billion in 2021 and forecast it would expand to nearly $30 billion by 2030, marking a CAGR of 5.36% for the period. Projected growth is attributed to factors like the rising prevalence of chronic pain across the world, coupled with a growing global geriatric population. In addition, increasing demand for OTC NSAIDs and the rising adoption of NSAIDs in treating headaches, migraine, toothaches and menstrual pain is expected to boost market growth.

Fortune Business Insights estimated that the global cosmeceuticals market was worth $54.57 billion in 2022 and projects the market will grow to a value of $96.23 billion by 2029, marking a CAGR of 8.4% during the forecast period. The report credits the projected growth to the prevalence of skin disorders around the world and the inclination of dermatologists to prescribe or recommend these products as compared to other treatments.

SOHM envisions a future where it evolves into a prominent global corporation, expanding its reach across international borders while upholding its fundamental core values. The company aspires to extend its export portfolio to encompass 11 countries, showcasing a robust international presence.

Aiming for financial stability, SOHM is committed to maintaining sufficient working capital to support its growth endeavors. The company’s forward trajectory involves strategic collaborations, mergers with diverse brands and a focused approach to business expansion through vertical integration and a balanced mix of organic and inorganic strategies.

In this pursuit, SOHM is dedicated to establishing its proprietary network of partners within the over the counter (OTC) sector. Furthermore, the company seeks heightened recognition within crucial therapeutic domains, including oncology, HIV, cardiovascular health, diabetes care and skincare-dermatology, solidifying its prominent standing in these pivotal segments.

Management Team

Baron Night is CEO, President, and Director at SOHM Inc. He has over 40 years of experience in various industries with extensive contacts in emerging markets. His leadership and track record are great assets to the company as SOHM continues to strengthen its position and develop large-scale distribution of generic drug lines.

David Aguliar, Ph.D., is the COO of SOHM. He has 22 years of experience in the pharmaceutical industry, including multiple research positions and scientific publications. He has an extensive background in pharmaceutical Chemistry Manufacturing and Controls (CMC), as well as quality assurance experience in preclinical and Investigational New Drug (IND) application filings of allogeneic cell-based therapies. He has a deep understanding of regulatory and clinical pathways, coupled with an extensive scientific and technical background in the fields of pharmaceuticals, biopharmaceuticals and gene editing tools research.

Dr. Krishna Bhat, MD PHD, FACC, has a cardiology practice of over 35 years in the field of Clinical and Interventional Cardiology. He is a recipient of the 2021 Hall of Fame Award from the American Heart Association, which was awarded in recognition of his commitment to excellence in the field of Cardiovascular Care through his leadership as an outstanding physician, researcher, and educator. He is also a recipient of the Miles Canada Fellowship Award and the J. Louis Levesque Fellowship Award from Montreal Heart Institute in Montreal, Canada.

Dewey Rushing is a Senior Compliance Remediation and Quality Professional with over 30 years of experience in Quality Assurance and cGMP Compliance for products regulated by the U.S. Food and Drug Administration (FDA). He served as a trained Consumer Safety Investigator at the FDA and Instructor at the Los Angeles District. He has in-depth knowledge in technology transfer of biologics and pharmaceutical products, as well as validation of manufacturing equipment, facility cleaning and critical utility systems maintenance. He has an extensive background in auditing GMP facilities, implementing quality systems and performing gap assessments of manufacturing processes and facilities. He has also directed remediation projects in response to federal compliance audit observations.

Sowmya Jacob, MBA-PGP, possesses over a decade of accomplished and evolving expertise in human resources management, along with manufacturing and operations management. She earned an MBA, complemented by advanced marketing certifications. Demonstrating a track record of achievement, she excels in cultivating collaborative work environments and orchestrating transformative changes that lead to heightened productivity. With adeptness in business analysis, she has occupied senior managerial roles, showcasing her mastery. An engaged participant in professional circles, she maintains active memberships in SPHR and CHRP.

SOHM Inc. (OTC: SHMN), closed Tuesday's trading session at $0.0019, up 26.6667%, on 15,647,254 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.15/$.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

Reflex Advanced Materials (CSE: RFLX) (OTCQB: RFLXF) (FSE: HF2), a mineral exploration company, has sold 100% interest in its ZigZag Lake Lithium property to Metals Corp. The property is located near Crescent Lake, Ontario. The purchase agreement was dated Jan. 8, 2024. According to the announcement, Metals Corp. paid $400,000 to Reflex and issued one million common shares for the property. The announcement noted that, in connection with the closing of the acquisition, Reflex exercised its option in accordance with the mineral property option agreement dated Sept. 1, 2021, following which it conveyed the property title to the purchaser. According to the agreement, consideration shares will be subject to a hold period under applicable securities laws; that hold period will expire four months and one day after the consideration shares are issued or the purchaser becomes a reporting issuer in any province or territory of Canada, whichever is later. In addition, the shares will be subject to a 24-month escrow release schedule with 250,000 shares being released every six months following issuance.

To view the full press release, visit

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.


Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Tuesday's trading session at $0.1617, off by 14.6477%, on 23,607 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0648/$0.765.

Recent News

Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

Correlate (OTCQB: CIPI), a growth-oriented distributed energy company, today announced the appointment of Johan Themaat as CFO of Correlate Energy Corp, effective immediately. His extensive financial background and proven track record make him a valuable asset to the company's executive team. In addition and in conjunction with this appointment, Correlate welcomes two distinguished professionals, Dr. Christine Gulbranson and Alina Zagaytova, to its board of directors. Their extensive experience and expertise will undoubtedly contribute to the strategic vision and growth of the company. Themaat brings a wealth of financial acumen to the role of CFO, having held key positions at prominent companies such as Mission Energy, NGL Energy Partners and RBS. Dr. Gulbranson, the founder of Nova Global Ventures, brings a wealth of knowledge and experience in the realms of AI and disruptive technology. Zagaytova, an experienced board director and a seasoned legal and corporate strategist, brings significant expertise in corporate and public company governance, M&A and finance.

To view the full press release, visit

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Tuesday's trading session at $1.85, up 2.7778%, on 1,832 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.3501/$2.35.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

Software Effective Solutions (OTC: SFWJ) (d/b/a MedCana), a global infrastructure and holding company in the cannabis industry, was featured in the latest episode of the Bell2Bell Podcast, a part of IBN's sustained effort to provide specialized content distribution via widespread syndication channels. Jose Gabriel Diaz, CEO of Software Effective Solutions, joined the program to provide an introduction to MedCana and its business model. "We are a U.S.-based holding company focused on developing infrastructure and cannabis companies around the world. Right now, the focus is primarily on markets outside of the U.S. that have already fully legalized pharmaceutical (and possibly some recreational) cannabis. We're looking at Switzerland, Germany, Portugal, Spain and most of Europe, as well as Australia, Brazil, Argentina and Uruguay… Our focus, initially, is not going to be into the United States, until there is a 100% guarantee that everything we're doing is on the legal side," Diaz said. "The focus is for MedCana to develop these companies that we've acquired outside of the U.S. to grow a presence in these international markets. It's not just cultivation that we're doing, however. MedCana is an infrastructure company. We also have two other very important companies. One is focused on software to make sure that certifications are being managed by our companies, but not just our companies. These are software products that we will be selling to other companies as we develop them. We also are very focused on infrastructure development of not just cannabis but technology in agriculture… So, it's developing these markets for the companies that we bought with the licenses. It's also focusing on infrastructure and software, along with the electronic resource planning and software management of these companies."

To view the full article, visit

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.


MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Tuesday's trading session at $0.0598, off by 13.3333%, on 600 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.098.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software and services, continues to receive recognition from authors at InvestorPlace. In addition to being featured by Louis Navellier and the InvestorPlace Research Staff, contributor Josh Enomoto listed D-Wave as one of "The 3 Hottest Quantum Computing Stocks to Watch in 2024" just last week.

Navellier wrote, "D-Wave Quantum is a quantum computing company. Quantum computing represents the next generation of computing technology, as it uses quantum bits to perform calculations much faster than traditional computers. That gives them a tremendous advantage over classical computers, which are binary code-based machines that use transistor technology."

When Enomoto provided his perspective, he wrote about D-Wave's ability to attract Alphabet's Google and the University of Southern California as early customers. He also pointed out that "analysts anticipate great things from QBTS, pegging it a unanimous strong buy with a $2.17 price target" before stating "that makes it one of the hottest quantum computing stocks based on implied growth."

To view Navellier's article, visit

To visit Enomoto's article, visit

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer


With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service


D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Tuesday's trading session at $0.8481, off by 3.625%, on 709,378 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.3962/$3.20.

Recent News

SenesTech Inc. (NASDAQ: SNES)

The QualityStocks Daily Newsletter would like to spotlight SenesTech Inc. (NASDAQ: SNES).

SenesTech Inc. (NASDAQ: SNES) is the rodent fertility control expert and the inventor of the only EPA-registered contraceptive for male and female rats. The company’s technology provides an innovative and humane method for managing rat populations.

SenesTech is focused on developing effective solutions that are grounded in science and proven through research, all while providing value to people, communities and the environment. The company’s passion is to create a healthier world by better controlling rat pest populations. This aim is critical, as, if left unchecked, a breeding pair of rats and their descendants can produce up to 15,000 pups after just one year.

The company strives for clean cities, efficient businesses and happy households – with a product that was scientifically designed to be effective without killing rats. SenesTech is committed to the sustainable, humane treatment of animals, improving the quality of all human life and enhancing environmental stewardship through the global application of its effective solution in fertility control technology.

SenesTech is headquartered in Phoenix, Arizona.


SenesTech’s first product, ContraPest®, applies revolutionary technology to a global challenge that has persisted since the Middle Ages – the proliferation of rats in urban and agricultural settings. ContraPest® targets the reproductive capabilities of Norway and roof rats. As a highly palatable liquid, the formulation promotes sustained consumption, helping to reduce fertility in both male and female rats, bringing populations down and keeping them down.

The company’s flagship offering can be used as part of integrated pest management (IPM) programs – fitting seamlessly into all IPM programs – to help reduce reproduction and magnify the success of these protocols, or as a standalone solution for customers who want to reduce or eliminate the use of lethal rodent control methods.

In multiple, independent field deployments, ContraPest was shown to reduce rat activity over 90% when added to an existing IPM program.

ContraPest® is registered federally as a General Use Product.

Delivery Systems and New Products

In July 2023, SenesTech began to distribute a new delivery system for ContraPest®, the Isolate Bait System™. This new delivery system brings to market a simple design that enables more efficient deployment, incorporates an enhanced formulation of ContraPest® that is expected to provide improved performance of the fertility control bait in the field and is paired with a new bait station that is more space-efficient and economical.

The other delivery systems available for ContraPest include the Ultimate Bait System™, a tank and tray in a larger format for use with more severe infestations, and the Elevate Bait System™, a unique delivery system that targets above ground infestations, as with roof rats.

SenesTech, as of August 2023, is also in the final stages of releasing a soft bait formulation, which provides the unique attributes of proven fertility control in an industry-familiar format demanded by big box retailers, key e-commerce channels and leading industry pest management professionals.

Market Opportunity

According to SenesTech’s figures, rats cause over $27 billion in damage to public and private infrastructure annually in the United States. Rats also destroy 20% of the global stored food supply every year by consuming or contaminating it.

Rats are known to spread at least 35 diseases, globally posing a dangerous risk to public health and safety. Not only does this age-old problem persist despite extensive campaigns to eradicate it, but multiple sources have reported that post-COVID rat populations have boomed.

Poison-based control methods sicken rats, and they typically die slowly. An animal that eats a poisoned rat may also sicken or die. The global rodenticide market is projected to be worth $1.7 billion by 2026.

In one case study, results reported by the customer showed a $5,000 investment in ContraPest® saved more than $500,000 annually in reduced labor, loss and damage.

Management Team

Joel Fruendt is SenesTech’s President and CEO. He has 15 years of executive leadership in the vector and pest control industries as Vice President and General Manager of Clarke Environmental Inc., a leading vector and pest control products and services company. He has extensive expertise in the development and manufacturing of EPA-registered chemical control products, and the commercialization and sale of those products. He received the ‘Smart Leaders’ award from Smart Business Magazine and holds a bachelor’s degree in business from Illinois Wesleyan University.

Tom Chesterman is CFO at SenesTech. He has over 20 years of experience as the CFO of public companies in the life science, tech and telecommunications industries. Most recently, he was the Vice President and Treasurer of GCI, a telecommunications company. Previous to that, he was the CFO of life science companies Bio-Rad Laboratories, Aradigm and Bionovo. He has a bachelor’s degree from Harvard University and an MBA from the University of California at Davis.

Dan Palasky is Chief Technical Officer at SenesTech. Previously he held the title of Vice President of Research & Development at PLZ Corp., a manufacturer of chemical consumer products, serving as the technical expert for its entire product portfolio. He started his career with Camie-Campbell, Inc., as a chemist in the R&D department. Mr. Palasky received his bachelor’s degree in chemical engineering from the Missouri University of Science & Technology and his MBA in Project Management from Aspen University.

SenesTech Inc. (NASDAQ: SNES), closed Tuesday's trading session at $1.21, off by 4.7244%, on 445,724 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.52/$80.952.

Recent News


The QualityStocks Daily Newsletter would like to spotlight GEMXX Corp. (OTC: GEMZ) .

GEMXX Corp. (OTC: GEMZ) is a mine-to-market enterprise specializing in gold, gemstone, and jewelry production. With ownership of mining resources, production facilities, and operational assets, the company maintains control over every aspect of its production process, from gold mining and gemstone extraction to jewelry manufacturing and global distribution.

As a prominent player in the industry, GEMXX stands out as a leading producer of high-quality finished Ammolite jewelry. Notably, it holds the distinction of being the sole public company engaged in Ammolite mining worldwide. In addition to its Ammolite operations, the company is actively involved in gold mining and prides itself on its ability to design and manufacture exquisite jewelry pieces and exceptionally rare, natural fossil decor items for clientele around the globe.

One of GEMXX’s key advantages lies in mining its own gold reserves to be utilized in its jewelry production. This strategic approach provides the company with a cost-saving edge over other producers in the market.

Ammolite is similar to black opal and is a biogenic gem like amber and pearl. It is derived from the fossilized shells of ammonites, a group of extinct marine nautiluses.

GEMXX’s world class gemstone cutters and jewelry designers are continuously leading the Ammolite industry. Its team believes in the company’s philosophy, vision and goals, and works every day to continue to drive the Ammolite industry to the forefront of the gem world.

The company has offices in Las Vegas and Hong Kong.

Projects and Operations

GEMXX has formulated an ambitious growth plan that, while challenging, is deemed attainable. The company’s strategy revolves around bolstering its market share through several key initiatives. Firstly, GEMXX aims to strengthen its position in current markets by nurturing and expanding existing relationships with customers and partners.

Secondly, the company plans to venture into untapped markets strategically. By identifying and targeting new areas, GEMXX seeks to establish a presence in regions that present promising opportunities for growth.

Additionally, GEMXX envisions growth through acquisitions. By considering and integrating key services, distribution networks and retail outlets into its fold, the company aims to consolidate its market position and capitalize on synergies for enhanced success.

To cater to the rising demand for its products, GEMXX has placed a primary focus on increasing gemstone production. The company’s southern properties, situated in Alberta, Canada, hold valuable deposits of rough Ammolite gemstone. By tapping into these resources, GEMXX is poised to meet the demand for its exquisite gemstone products and further fuel its expansion plans.


GEMXX possesses significant mineral assets in the form of a Mineral Work Permit covering an 800-acre area and two Ammonite Shell Mineral agreements encompassing 217 acres within the same region. The company’s management effectively operated mines in close proximity to these properties. Moreover, core sampling, along with fossil outcroppings on the riverbanks, confirms a substantial Ammolite resource present in these designated areas.

Both the Mineral Work Permit and the Ammonite Shell Mineral agreements grant GEMXX unrestricted access to all Ammolite resources within their respective demarcations. Notably, the company is not obligated to pay any royalties to third parties, thereby enabling GEMXX to fully capitalize on the potential of these valuable resources.

Furthermore, there are no stringent regulatory conditions that GEMXX must fulfill to gain or retain access to the Ammolite deposits. This freedom of access allows the company to proceed with its mining and production operations unimpeded, providing an advantageous position for future growth and success.

In March 2023, GEMXX made a significant announcement, revealing its acquisition of a 50% ownership stake in Crazy Horse Mining Inc., a Canadian gold mining company with assets situated in the province of British Columbia. As part of this deal, Crazy Horse’s assets, which encompass a 100% interest in two gold projects, called Snow Creek and Rosella Creek, spread across a substantial area exceeding 700 acres, now become part of GEMXX’s portfolio.

Under the terms of this strategic partnership, GEMXX and Crazy Horse will jointly share the expenses related to mining operations on these projects. Additionally, the two companies will share the gold produced from these ventures, leading to a collaborative and mutually beneficial arrangement.

Initial tests conducted on the property, combined with gold already recovered this season, confirm all expectations for the claims and substantiate the company’s estimated extraction target of over 100,000 ounces of easily recoverable gold. To validate and provide a more comprehensive assessment of this estimate, an S-K 1300-compliant Resource Report is scheduled to be conducted during the summer of 2023.

By acquiring this stake in Crazy Horse Mining Inc., GEMXX has positioned itself for further growth in the gold mining sector and is poised to capitalize on cost of goods savings in its jewelry business.

Market Opportunity

Leading independent market research companies such as Data Monitor and GIA estimate the worldwide market for luxury or premium lifestyle products, which include gems and jewelry, at over $90 billion annually and growing. Ammolite sales around the world have seen unprecedented growth over the past 20 years. Worldwide retail sales are now estimated to be over $100 million.

Ammolite jewelry and fossils are featured aboard cruise ships and can be found in specialty shops in almost every cruise port in North America. Asian markets have grown since feng shui master Edward Li called Ammolite the most influential stone of the new millennium, referring to it as the “Seven Color Prosperity Stone.” Home shopping channels in Japan, Australia, France, Germany, the UK, Canada and the U.S. have all featured Ammolite jewelry.

Ammolite and ammonites can also be found on many ecommerce sales platforms, including Amazon, eBay and Etsy. Ammolite is sold around the world in tourist and traditional jewelry markets. The company has established customers in home shopping channels, cruise tourism, jewelry retailers, Asian feng shui markets, Asian retail markets and ecommerce platforms.

Management Team

With over 160 years in Ammolite management, operations, and sales, GEMXX possesses an unparalleled wealth of knowledge and expertise. Its team members have extensive backgrounds in every facet of the Ammolite business, allowing the company to excel in product development, maintain rigorous quality control measures, and maximize profitability. The breadth and depth of the GEMXX team’s experience enable the company to navigate the industry with precision, ensuring that GEMXX remains at the forefront of the Ammolite market. GEMXX leverages its collective wisdom to drive innovation, deliver exceptional products, and optimize business strategies to achieve long-term success.

Jay Maull is Founder, CEO and Chairman of GEMXX. With a career spanning more than three decades, he has been deeply involved in the Ammolite industry, from mining and production to marketing. He has owned and operated the world’s largest Ammolite mine and has delivered exceptional Ammolite products to customers across all continents. He has also established the world’s largest Ammolite ecommerce platform.

Richard Clowater is President of GEMXX. He is a skilled sales and marketing professional with a focus on research, data analysis and strategic planning. He has successfully implemented initiatives to expand markets, boost profits and foster customer loyalty. He has an impressive track record of negotiating sales and contracts worth over $250 million with influential stakeholders, including key purchasing personnel, C-suite executives and government entities at all levels.

Tom Dryden is a Vice President of GEMXX and brings a wealth of experience and expertise to the production and marketing of Ammolite, spanning over 30 years. His extensive involvement in the industry has granted him unparalleled knowledge of the Bearpaw Ammonite bearing formations. As a recognized authority in the field, Mr. Dryden’s research and papers on Canadian Ammonites have garnered global recognition, being published worldwide. In his role at GEMXX, Mr. Dryden assumes the responsibility of overseeing the company’s Canadian-based production facilities. 

P. K. Chung is Business Manager Asia at GEMXX. With a track record of over 25 years in Ammolite business management, production and marketing in Asia, she is a recognized authority in the industry. Based in the Hong Kong gem district, she possesses an intricate understanding of the Asian gem and jewelry markets, including market dynamics, consumer preferences and industry trends specific to the region. Her strategic insights and deep connections enable GEMXX to thrive in this influential market.

GEMXX Corp. (OTC: GEMZ), closed Tuesday's trading session at $0.035, up 2.9412%, on 110,334 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.023/$0.798.

Recent News

Fintech Ecosystem Development Corp. (NASDAQ: FEXD)

The QualityStocks Daily Newsletter would like to spotlight Progressive Care Inc. (OTCQB: FEXD).

Fintech Ecosystem Development Corp. (NASDAQ: FEXD) is a special purpose acquisition company (SPAC) formed for the purpose of effecting one or more business combinations with an intent to focus on the financial technology sector.

The company’s mission is to create and grow a global financial services ecosystem to address unmet mobile money needs in developing and industrialized countries and markets. FEXD plans to achieve this by acquiring and merging with financial technology pioneers that have the potential to help establish its global fintech ecosystem, and by continuing the development of proprietary technologies and applications to keep the company at the forefront of the cashless society market.

Digital money is replacing physical cash. Consumers can buy products and services from anywhere in the world and make payments across borders. Parents can send money to students studying in other countries. Migrant workers are sending money to families in developing nations. Rural villagers without banks can send and receive money using their smartphones. FEXD is developing mobile transaction platforms, applications and services that are helping to implement these changes.

The company plans to offer a diverse portfolio of products and services to consumers and businesses in the United States, South Asia, East Asia, Africa, Europe and Latin America. Its growth strategy includes acquisition, innovation and market development.

FEXD is a Delaware corporation based in Collegeville, Pennsylvania. The company was launched in May 2021 by a management team led by Dr. Saiful Khandaker that has extensive experience in developing and managing financial service platforms and applications, primarily in the mobile money sector. FEXD is sponsored by Revofast LLC.

Acquisition Targets

In September 2022, FEXD announced definitive agreements for business combinations with Rana Financial Inc., a Georgia corporation, and Mobitech International LLC (dba Afinoz), a limited liability company organized in the United Arab Emirates. The agreements call for Rana and Afinoz to become wholly owned subsidiaries of FEXD, with the combined company expected to continue trading on the Nasdaq under existing ticker symbol ‘FEXD’. The mergers are expected to close in Q2 2023.

Rana Financial

Rana Financial is a licensed money transfer company founded in 2009. Rana provides fast and affordable online and mobile transfer of funds between the U.S. and Latin America. Rana has been providing money transfer services in the U.S. market for 13 years and has 30,000 active users. Rana’s money transfer business grew to 200,000 transactions in 2021. The merger agreement values Rana at an implied $78 million enterprise value.

Mobitech International LLC

Mobitech International LLC (dba Afinoz) is an artificial intelligence-enabled digital lending platform used by India’s leading banks, non-banking financial companies and fintech loan providers. Afinoz’s fintech platform supports enterprises making loans primarily to middle- and working-class borrowers via its website or through its mobile phone application. Afinoz’s platform makes loans available and affordable to millions of Indian workers and unbanked users by providing access at a low cost. Afinoz’s platform has more than 50 lending partners, and its database of registered users in India includes more than two million individuals. The merger agreement values Afinoz at an implied $120 million enterprise value.

Market Opportunity

According to analysis by global market research firm Mordor Intelligence, the worldwide financial technology market is valued at approximately $194 billion in 2023 and is projected to grow to nearly $500 billion by 2028, representing a CAGR of 18.97% for the forecast period. According to the report, various financial crises and the COVID-19 pandemic have fueled consumer adoption of, and investor interest in, fintech over the past several years.

Management Team

Dr. Saiful Khandaker is Founder, CEO and President of FEXD. He is Group CEO and founder of FAMA Holdings Inc., a global developer of fintech platforms, applications and services based in the U.S. with offices in the U.K., India, Bangladesh and Zambia. He is currently leading the development of the FAMACASH™ network, a global fintech ecosystem to provide fast, affordable mobile money services in underserved countries such as Bangladesh. Before founding FAMA, Dr. Khandaker spent more than two decades leading the development of software solutions for Fortune 100 companies and startups. He also helped numerous clients modernize their fintech services as Chief Technology Officer at Mi3. He holds a Doctor of Management in Organizational Leadership, a Master of Science in Technology Management, and a Bachelor of Science in Computer Information Systems.

Jenny Junkeer is CFO at FEXD. She is a Chartered Accountant with over 17 years of experience. As CEO of Junkeer New Era Consulting, she leads a team specializing in helping companies launch and optimize business operations in fast-changing industries. She has extensive experience helping organizations scale operations to maximize value. She is an Adjunct Association Professor at Deakin University in Australia, a board member of the Global Health Initiative Foundation, and Director of Implementation at ConnectCV. She holds a Bachelor of Commerce Degree (Honors) from Monash University.

FingerMotion Inc. (FEXD), closed Tuesday's trading session at $10.75, even for the day, on 4,710 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $10.27/$11.00.

Recent News

Genprex Inc. (NASDAQ: GNPX)

The QualityStocks Daily Newsletter would like to spotlight Genprex Inc. (NASDAQ: GNPX).

Genprex Inc. (GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.

Research and Development

Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.

Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.

Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.

Clinical Trials

Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.

TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.

The Market

Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.

Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.

Senior Management

Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.

Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.

Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.

Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.

Genprex Inc. (NASDAQ: GNPX), closed Tuesday's trading session at $0.2328, off by 16.9461%, on 783,126 volume. The average volume for the last 3 months is 376,208 and the stock's 52-week low/high is $0.1903/$1.87.

Recent News

Mountain Top Properties Inc. (OTC: MTPP)

The QualityStocks Daily Newsletter would like to spotlight Mountain Top Properties Inc. (OTC: MTPP).

Mountain Top Properties Inc. (OTC: MTPP) is a diversified real estate holding company that acquires, sells and operates assets through its wholly owned subsidiaries and limited partnerships. The company specializes in property management, property technology (“PropTech”) and real estate redevelopment.

Mountain Top Properties was incorporated in 1990 and is based in Liverpool, New York, with offices in Sag Harbor, New York.


The company’s flagship subsidiary is Mountain Top Realty Inc., the managing partner of its first real estate fund focused on residential redevelopment in the prestigious and storied Hamptons, New York, beachfront communities.

Mountain Top Properties is also the lead investor in blockchain-enabled industrial and warehouse flex space HQXpress, which services the warehousing, reverse logistics and liquidation markets.

The company is in negotiations for the addition of AI-powered technologies that promise to simplify real estate services, including purchasing and sales.

Mountain Top Capital Fund I LLC

Mountain Top Capital Fund I LLC is a New York limited liability company recently organized by affiliates of Mountain Top Realty, manager of the fund. Through this fund, Mountain Top Realty will leverage the company’s experience, market conditions and industry relationships to capitalize on real estate projects as they arise.

This partnership will be focused on waterfront or water view properties in the Hamptons. The Hamptons market has historically remained strong and continues to set new highs year over year.

The fund has partnered with On Site Builder Construction Co. Inc., which is managed by Joseph Kelley, who, for over 40 years, has continued to build the highest quality architecturally designed custom houses, varying in style from classic to ultra-modern, in the Hamptons. Several houses he has built are showcased in books and magazines and featured across various forms of digital and social media. His assembled team of skilled subcontractors are among the finest skilled craftsmen in their various fields of expertise.

Mr. Kelley has built over 60 custom homes in this market and has the unique distinction of building the most expensive house sold in Sag Harbor in 2014, which sold for $31,750,000; the most expensive house in the Hamptons in 2019, which first sold for $27,500,000 in 2017 and later was renovated and re-traded for $39,250,000; and the most expensive house sold in the Hamptons in 2022, which sold with the neighboring house for $118,500,000. Mr. Kelley’s portfolio of projects is valued at over $400,000,000. Although he has historically worked as a custom home builder, he would like to shift from providing a service to now providing a finished product in this market.

Market Opportunity

Mountain Top Capital Fund I has a target to raise $75 million to acquire, renovate and remarket Hamptons waterfront or water view properties. The fund has secured debt capital commitments for 70% of the acquisition costs and 100% of the construction costs and will use $10 million to leverage strategic waterfront opportunities in and around the Hamptons.

Profits from each project will be distributed upon the sale of the project, which is anticipated every 15 to 18 months, with a target of a minimum return on investment of 20% to 30% per transaction.

The company anticipates the fund’s Hamptons projects will be followed up by several other funds targeting additional high-end markets.

Management Team

Beau Kelley is CEO, President, CFO and Director of Mountain Top Properties.

Mountain Top Properties Inc. (OTC: MTPP), closed Tuesday's trading session at $0.0788, off by 10.4545%, on 23,505 volume. The average volume for the last 3 months is 18,667 and the stock's 52-week low/high is $0.0083/$0.1898.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More



In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.


Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Tuesday's trading session at $0.3354, up 0.419162%, on 144,302 volume. The average volume for the last 3 months is 1.567M and the stock's 52-week low/high is $0.32/$2.695.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal

The QualityStocks Sponsored News

The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.